167 related articles for article (PubMed ID: 34189022)
1. Mothers' preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study.
Sargazi N; Takian A; Yaseri M; Daroudi R; Ghanbari Motlagh A; Nahvijou A; Zendehdel K
Prev Med Rep; 2021 Sep; 23():101438. PubMed ID: 34189022
[TBL] [Abstract][Full Text] [Related]
2. Mothers' Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters: A Discrete Choice Experiment in Hong Kong.
Wong CKH; Man KKC; Ip P; Kwan M; McGhee SM
Value Health; 2018 May; 21(5):622-629. PubMed ID: 29753361
[TBL] [Abstract][Full Text] [Related]
3. Parents' preferences and willingness-to-pay for human papilloma virus vaccines in Thailand.
Ngorsuraches S; Nawanukool K; Petcharamanee K; Poopantrakool U
J Pharm Policy Pract; 2015; 8(1):20. PubMed ID: 26199734
[TBL] [Abstract][Full Text] [Related]
4. Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus.
Brown DS; Johnson FR; Poulos C; Messonnier ML
Vaccine; 2010 Feb; 28(7):1702-8. PubMed ID: 20044060
[TBL] [Abstract][Full Text] [Related]
5. Cost-Benefit Analysis of Human Papillomavirus Vaccine in Iran.
Sargazi N; Takian A; Daroudi R; Nahvijou A; Yaseri M; Ghanbari Motlagh A; Zendehdel K
J Prev (2022); 2022 Dec; 43(6):841-857. PubMed ID: 35916995
[TBL] [Abstract][Full Text] [Related]
6. Adolescent girls' preferences for HPV vaccines: a discrete choice experiment.
Brown DS; Poulos C; Johnson FR; Chamiec-Case L; Messonnier ML
Adv Health Econ Health Serv Res; 2014; 24():93-121. PubMed ID: 25244906
[TBL] [Abstract][Full Text] [Related]
7. Parental preferences for HPV vaccination in junior middle school girls in China: A discrete choice experiment.
Zhu S; Chang J; Hayat K; Li P; Ji W; Fang Y
Vaccine; 2020 Dec; 38(52):8310-8317. PubMed ID: 33223307
[TBL] [Abstract][Full Text] [Related]
8. Mothers' willingness to accept and pay for vaccines to their children in western Iran: a contingent valuation study.
Rezaei S; Woldemichael A; Mirzaei M; Mohammadi S; Karami Matin B
BMC Pediatr; 2020 Jun; 20(1):307. PubMed ID: 32576156
[TBL] [Abstract][Full Text] [Related]
9. Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment.
Darrudi A; Daroudi R; Yunesian M; Akbari Sari A
Pharmacoecon Open; 2022 Sep; 6(5):669-679. PubMed ID: 35997900
[TBL] [Abstract][Full Text] [Related]
10. Mothers' willingness to pay for HPV vaccines in Anambra state, Nigeria: a cross sectional contingent valuation study.
Umeh IB; Nduka SO; Ekwunife OI
Cost Eff Resour Alloc; 2016; 14():8. PubMed ID: 27274335
[TBL] [Abstract][Full Text] [Related]
11. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
[TBL] [Abstract][Full Text] [Related]
12. The effects of convenience and quality on the demand for vaccination: Results from a discrete choice experiment.
Guo N; Zhang G; Zhu D; Wang J; Shi L
Vaccine; 2017 May; 35(21):2848-2854. PubMed ID: 28410814
[TBL] [Abstract][Full Text] [Related]
13. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M
Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953
[TBL] [Abstract][Full Text] [Related]
14. German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
Poulos C; Curran D; Anastassopoulou A; De Moerlooze L
Vaccine; 2018 Feb; 36(7):969-978. PubMed ID: 29338877
[TBL] [Abstract][Full Text] [Related]
15. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
16. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].
Moro D; Schlander M; Telser H; Sola-Morales O; Clark MD; Olaye A; Camp C; Jain M; Butt T; Bakshi S
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):581-598. PubMed ID: 34877915
[TBL] [Abstract][Full Text] [Related]
17. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
Brisson M; Laprise JF; Drolet M; Van de Velde N; Franco EL; Kliewer EV; Ogilvie G; Deeks SL; Boily MC
Vaccine; 2013 Aug; 31(37):3863-71. PubMed ID: 23830974
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, acceptance, and willingness to pay for human papilloma virus (HPV) vaccination among female parents in Thailand.
Kruiroongroj S; Chaikledkaew U; Thavorncharoensap M
Asian Pac J Cancer Prev; 2014; 15(13):5469-74. PubMed ID: 25041020
[TBL] [Abstract][Full Text] [Related]
19. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
Xiao J; Wang F; Wang M; Ma Z
Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117
[TBL] [Abstract][Full Text] [Related]
20. Mothers' willingness to pay for daughters' HPV vaccine in northern Vietnam.
Dinh Thu H; Nguyen Thanh H; Hua Thanh T; Nguyen Hai L; Tran Thi V; Nguyen Manh T; Buvé A
Health Care Women Int; 2018 Apr; 39(4):450-462. PubMed ID: 29210616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
